Synthorx
ID: 5304840Synthetic biology company that created novel DNA base pairs and uses them to incorporate novel amino acids into proteins for potential therapeutics in areas of cancer and autoimmune disorders.
5
Funding Rounds
$152.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Fl*** Ro******* | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Synthorx has raised a total of $73m in funding over 5 rounds.
Key Insights:
- Synthorx Series C round, April 2018: $63m
- Synthorx Series B round, July 2016: $10m
- Synthorx Series B Funding Round July 2016: $10m
- Synthorx Series C Funding Round April 2018: $63m
- Synthorx Series A Funding Round April 2014: $6m
Industries
Synthorx is active in the following industries: